Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Race Oncology Ltd. ( (AU:RAC) ) just unveiled an announcement.
Race Oncology Ltd. announced a change in the director’s interest, specifically involving Daniel Tillett. The change includes the cashless exercise of 2,000,000 options and the issuance of 432,680 new options, which were approved at the company’s recent AGM. This adjustment in securities reflects strategic financial maneuvers that could impact the company’s stock and stakeholder interests.
More about Race Oncology Ltd.
Race Oncology Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of cancer therapies. The company is known for its innovative approaches to cancer treatment, aiming to address unmet medical needs in oncology.
Average Trading Volume: 546,429
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$514.5M
Learn more about RAC stock on TipRanks’ Stock Analysis page.